Executive Director, Late-Stage Oncology Clinical Operations

Job Description

Jazz Pharmaceuticals is seeking an experienced Executive Director for Late-Stage Oncology Clinical Operations to lead the execution and delivery of our Oncology Phase 1-3 pipeline. The ideal candidate will have extensive knowledge in solid tumor clinical development, strategic operational planning, project cost estimations, and global regulatory requirements. This role requires strong leadership skills to manage a high-performing clinical team, ensure project goals are met on time and on budget, and foster effective internal and external relationships.

Responsibilities

• Direct all operational aspects of the late-stage oncology clinical development pipeline.
• Assure accuracy and appropriateness of clinical research budgets and timelines.
• Influence development teams to enable high-quality clinical trial protocols and plans.
• Analyze and address issues with investigational sites, CRAs, and CROs.
• Provide mentorship to staff, set aligned goals, and manage high-performing clinical teams.
• Collaborate with cross-functional teams to ensure operational excellence.

Requirements

• Minimum of fifteen years of experience in pharmaceutical or biotechnology industry.
• Demonstrated expertise in oncology clinical research and regulatory requirements.
• Strong leadership, communication, and negotiation skills.
• Deep understanding of clinical operations and trial technology.
• Education: Bachelor's degree required, MBA or equivalent advanced degree preferred.

About Jazz Pharmaceuticals

Jazz Pharmaceuticals is dedicated to developing life-changing medicines for patients with serious diseases, with a focus on neuroscience and oncology. We offer a competitive compensation package, including base pay within the range of $256,000-$384,000, annual cash bonus or incentive compensation, equity grants, and comprehensive benefits such as medical, dental, vision insurance, and retirement savings plan.